Johnson John Paul 4
4 · Evolent Health, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Johnson John Paul
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2023-03-01+20,413→ 212,717 total - Tax Payment
Class A Common Stock
2023-03-01$35.26/sh−3,681$129,792→ 209,036 total - Tax Payment
Class A Common Stock
2023-03-02$35.15/sh−9,020$317,053→ 200,016 total
Footnotes (4)
- [F1]Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. Omnibus Incentive Compensation Plan.
- [F2]Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026.
- [F3]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F4]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.